“Black Ink” Sonographic Pattern as a Predictor for Invasive Papillary Thyroid Microcarcinoma: A Case Report | Chapter 01 | Emerging Research in Medical Sciences Vol. 2
Background:
This study investigated the utility of the Sonographic pattern "Black
Ink" with BRAF mutation testing of thyroid fine-needle aspiration cytology
specimens for the risk papillary thyroid microcarcinoma (PTMC).
Case
Presentation: We describe a case of a 41-year-old
Caucasian woman affected by a ultrasonography “Black Ink” papillary thyroid
microcarcinoma (PTMC) of the left lobe of the thyroid gland with very tiny size
(Ø 0.4 cm). The characteristics, with the Diagnostic Imaging using
Ultrasonography (US), Superb Micro-Vascular Imaging (SMI), fine-needle-aspiration
cytology (FNAC) and mutation analysis are here discussed. There are more rare
subtypes of thyroid cancer as papillary microcarcinoma "Black Ink"
that even if small, are invasive and there is why the need to early diagnosis
to avoid their aggressive behavior is needed. Nowadays, focusing on the size,
the cut-off for non-occult tiny tumors has dropped to 0.3 cm. This value is of
great relevance.
Conclusion:
Ultrasonography, FNAC and BRAF molecular study have proven to be the most
sensitive diagnostic combination for the early detection of thyroid cancer.
Despite the size of this micro-lesion, the Black Ink ultrasonographic pattern
associated with malignant cytology at FNAC represents an important biological
risk factor and could still be a predictor of the PTMC and risk for neck lymph
node metastases.
Author(s) Details
Ersilio Trapanese
Interventional Ultrasound of
Breast Oncology Screening, ASL Salerno, Italy.
Basilio Angrisani
Department of Anatomical
Pathology, Del Mare Hospital, ASL Naples, Italy.
Alberto Angrisani
Department of Biology,
University of Naples Federico II, Monte Sant’ Angelo University Complex, Italy.
Ermanno D’Arco
Department of Endocrine
Surgery, San Francesco d’Assisi Hospital, ASL Salerno, Italy.
Mariano Agrusta
Department of Endocrinology
and Diabetology, Cava Amalfi Hospital, ASL Salerno, Italy.
Carmine De Bartolomeis
Department of Endocrine
Surgery, Barbantini Private Hospital, Lucca, Italy.
Stefano Laudati
Department of Anatomical
Pathology, Del Mare Hospital, ASL Naples, Italy.
Giulio Tarro
President Foundation T.
& L. de Beaumont Bonelli for Cancer Research, Italy.
World Academy of Biomedical
Technologies (WABT), UNESCO, Paris, France.
Comments
Post a Comment